Akribes Biomedical GmbH
Back to list
Facts
- Founded
- Staff
- 5
- Organization type
- RDM medtech
Profile
Development of a new pharmacological treatment for chronic wounds, identified by implementation of the first assay platform for personalized medicine of chronic wounds. The proprietary assays combine diagnosis and therapy recommendations for individual chronic wound patients. A Ph1b/2a proof-of-concept study is planned for 2025.
Similar companies in RDM medtech
mySugr GmbH
- Organization type
- RDM medtech
- Cluster
- LISAvienna
Otto Bock Healthcare Products GmbH
- Organization type
- RDM medtech
- Region
- Vienna
- Cluster
- LISAvienna
- Topic
-
active implantable devices
assistive products for persons with disability
telemedicine and e-health
software for medicine
VIVISOL HeimbehandlungsgerÀte GmbH
- Organization type
- RDM medtech
- Region
- Vienna
- Cluster
- LISAvienna
- Topic
- anaesthetic and respiratory devices
Eurolyser Diagnostica GmbH
- Organization type
- RDM medtech
- Region
- Salzburg
- Cluster
- Medical Technology Cluster
- Topic
-
in vitro diagnostic devices
telemedicine and e-health
software for medicine
Contact
Contact: